Plus Therapeutics’ (PSTV) Buy Rating Reaffirmed at HC Wainwright
Plus Therapeutics (NASDAQ:PSTV – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $8.00 price objective on the stock. Separately, Ascendiant Capital Markets dropped their price target on Plus Therapeutics from $21.00 to $20.00 […]
More Stories
iShares MSCI Intl Quality Factor ETF (NYSEARCA:IQLT) Shares Sold by Carlson Capital Management
Carlson Capital Management decreased its stake in iShares MSCI Intl Quality Factor ETF (NYSEARCA:IQLT – Free Report) by 1.4% during...
Carlson Capital Management Trims Position in Dimensional US Marketwide Value ETF (NYSEARCA:DFUV)
Carlson Capital Management reduced its position in shares of Dimensional US Marketwide Value ETF (NYSEARCA:DFUV – Free Report) by 8.7%...
Sanders Capital LLC Sells 10,890,659 Shares of Medtronic plc (NYSE:MDT)
Sanders Capital LLC lowered its position in shares of Medtronic plc (NYSE:MDT – Free Report) by 85.1% in the 3rd...
Prospector Partners LLC Has $17.35 Million Stock Position in Colgate-Palmolive (NYSE:CL)
Prospector Partners LLC lessened its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 4.8% in the 3rd quarter, according to...
Brett (BRETT) Price Tops $0.16
Brett (BRETT) traded 5.2% lower against the dollar during the 1-day period ending at 11:00 AM E.T. on November 26th....
Solana Price Reaches $229.80 (SOL)
Solana (SOL) traded 5.5% lower against the U.S. dollar during the 24 hour period ending at 11:00 AM E.T. on...